- Home
- ASYS vs ALGS Comparison
ASYS vs ALGS Comparison
Compare ASYS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- ALGS
- Stock Information
- Founded
- ASYS 1981
- ALGS 2018
- Country
- ASYS United States
- ALGS United States
- Employees
- ASYS N/A
- ALGS N/A
- Industry
- ASYS Industrial Machinery/Components
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- ALGS Health Care
- Exchange
- ASYS Nasdaq
- ALGS Nasdaq
- Market Cap
- ASYS 59.4M
- ALGS 50.4M
- IPO Year
- ASYS N/A
- ALGS 2020
- Fundamental
- Price
- ASYS $4.48
- ALGS $7.84
- Analyst Decision
- ASYS
- ALGS Strong Buy
- Analyst Count
- ASYS 0
- ALGS 1
- Target Price
- ASYS N/A
- ALGS $70.00
- AVG Volume (30 Days)
- ASYS 33.8K
- ALGS 125.8K
- Earning Date
- ASYS 08-06-2025
- ALGS 08-05-2025
- Dividend Yield
- ASYS N/A
- ALGS N/A
- EPS Growth
- ASYS N/A
- ALGS N/A
- EPS
- ASYS N/A
- ALGS N/A
- Revenue
- ASYS $90,826,000.00
- ALGS $3,270,000.00
- Revenue This Year
- ASYS N/A
- ALGS N/A
- Revenue Next Year
- ASYS $28.60
- ALGS $51.55
- P/E Ratio
- ASYS N/A
- ALGS N/A
- Revenue Growth
- ASYS N/A
- ALGS N/A
- 52 Week Low
- ASYS $3.20
- ALGS $3.76
- 52 Week High
- ASYS $6.96
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- ASYS 59.76
- ALGS 57.02
- Support Level
- ASYS $4.33
- ALGS $6.82
- Resistance Level
- ASYS $4.68
- ALGS $8.66
- Average True Range (ATR)
- ASYS 0.26
- ALGS 0.76
- MACD
- ASYS 0.02
- ALGS -0.06
- Stochastic Oscillator
- ASYS 70.51
- ALGS 55.49
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.